| Santa Dalessio, MD | |
|
2055 Valley Ave, Winchester, VA 22601-2751 | |
| (540) 771-3032 | |
| (540) 713-0427 |
| Full Name | Santa Dalessio |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 31 Years |
| Location | 2055 Valley Ave, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275591919 | NPI | - | NPPES |
| 110235048 | Other | RAILROAD MEDICARE | |
| 1808081000 | Medicaid | WV | |
| 005869625 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0101231825 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center | Hagerstown, MD | Hospital |
| Winchester Medical Center | Winchester, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anacostia Medical Associates | 8123257821 | 31 |
| Anacostia Medical Associates | 8123257821 | 31 |
News Archive
Scientists have developed a new way to deliver anti-parasitic medicines more efficiently.
As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.
American Surgical Holdings, Inc. announced today that it has entered into a definitive merger agreement pursuant to which American Surgical will be acquired and taken private by AH Holdings Inc., an affiliate of Great Point Partners, I LP ("GPP"), a Greenwich, CT-based private equity fund.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
› Verified 8 days ago
| Entity Name | Shock Trauma Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679512909 PECOS PAC ID: 6800882317 Enrollment ID: O20040421000976 |
News Archive
Scientists have developed a new way to deliver anti-parasitic medicines more efficiently.
As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.
American Surgical Holdings, Inc. announced today that it has entered into a definitive merger agreement pursuant to which American Surgical will be acquired and taken private by AH Holdings Inc., an affiliate of Great Point Partners, I LP ("GPP"), a Greenwich, CT-based private equity fund.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
› Verified 8 days ago
| Entity Name | Anacostia Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376973362 PECOS PAC ID: 8123257821 Enrollment ID: O20190219000024 |
News Archive
Scientists have developed a new way to deliver anti-parasitic medicines more efficiently.
As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.
American Surgical Holdings, Inc. announced today that it has entered into a definitive merger agreement pursuant to which American Surgical will be acquired and taken private by AH Holdings Inc., an affiliate of Great Point Partners, I LP ("GPP"), a Greenwich, CT-based private equity fund.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Santa Dalessio, MD 2055 Valley Ave, Winchester, VA 22601-2751 Ph: (540) 771-3032 | Santa Dalessio, MD 2055 Valley Ave, Winchester, VA 22601-2751 Ph: (540) 771-3032 |
News Archive
Scientists have developed a new way to deliver anti-parasitic medicines more efficiently.
As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.
American Surgical Holdings, Inc. announced today that it has entered into a definitive merger agreement pursuant to which American Surgical will be acquired and taken private by AH Holdings Inc., an affiliate of Great Point Partners, I LP ("GPP"), a Greenwich, CT-based private equity fund.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
› Verified 8 days ago
Dr. Raveen Chawla, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Neal S Gaither, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Lee Resta, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Campus Blvd Ste 100, Winchester, VA 22601 Phone: 540-662-1108 | |
Kristine Gade Reed, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 400 Campus Blvd., Suite 100, Winchester, VA 22601 Phone: 540-662-1108 Fax: 540-450-2244 | |
Dr. David Jack Lecronier, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 190 Campus Blvd Ste 201, Winchester, VA 22601 Phone: 540-536-5980 Fax: 540-536-5979 | |
T. Glen Bouder, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8874 Fax: 540-536-7847 | |
Dr. Manish J Lakhani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 |